Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.

In vivo, the nanoplatform showed a trend toward increased primary tumor homing in an orthotopic CRC xenograft, even though statistical significance for the accumulation of GE11-modified micelles compared with plain ones was not reached.

also in 53,322 other papers